Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04744831
Title Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer (DESTINY-CRC02)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Daiichi Sankyo, Inc.
Indications

colorectal adenocarcinoma

Therapies

Trastuzumab deruxtecan

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST